Ivan Banović is appointed Business Development Manager for Consumer Healthcare Products Division in Rhei Life.
Menu
Menu
Ivan Banović is appointed Business Development Manager for Consumer Healthcare Products Division in Rhei Life.
Rhei Life is strengthening partnership with EL Pharma (Phoenix Group Member) and its presence in Bosnian market by signing agreement for 8 new Rhei Life products to be launched, marketed and promoted in Bosnia and Hercegovina.
Rhei Life BD team successfully participated on #PharmaSynergy 2021 that took place on February 23-25 in Amsterdam, Netherlands.
Iva Giba is appointed as Regulatory Affair Specialist, team in Rhei Life. She will be obtaining and maintaining MA approvals for medicinal products, medical devices and food suplements
The new partnership with Dr. Reddy`s Laboratories will enrich Rhei Life hospital portfolio in Serbia and Bosnia and Herzegovina with several medicines.
Efavirenz is used along with other medications to treat human immunodeficiency virus (HIV) infection. Even though this medicine was registered in Bosnia, a few years back shortages started, and the originator company withdrew it from the market. Our company imported it to fill the gap since it is still necessary in some therapeutical protocols. As a result of our partnership with a Portuguese pharma company we have stabilized the supply of this medicine to Bosnia and Herzegovina as a non-registered medicine.
The shortage of Vinblastine medicine in Poland initiated our partnership with a state-owned wholesale company CEFARM. Our company supplied Vinblastine manufactured in Argentina to Cefarm in Poland in order to cover a local shortage of this important medicine used to treat various types of cancer.
FIRST IMPORTATION TO SERBIAN MARKET OF TRIENTINE, A RARE DISEASE MEDICINE FOR WILSON DISEASE FROM US MARKET (TRIENTINE AMENAL PHARMACEUTICALS)
